Showing results (71-80 of 281) with videos related to
Sort By:
Pageof 29
Expert Opinion on Biological Therapy|May 15, 2008
Cintredekin besudotox in treatment of malignant gliomaMelike Mut, Jonathan H Sherman, Mark E Shaffrey, et al.Neurosurgery Clinics of North America|March 18, 2004
Intraventricular gliomasAaron S Dumont, Elana Farace, David Schiff, et al.Neuro-Oncology|August 12, 2021
Management of venous thromboembolism in high-grade glioma: Does low molecular weight heparin increase intracranial bleeding risk?Jasmin Jo, Joseph Donahue, Guneet Sarai, et al.Neuro-Oncology Practice|January 20, 2023
Navigating disability insurance in the American healthcare system for the low-grade glioma patientLalanthica Yogendran, Mark Rudolf, Drew Yeannakis, et al.Idrugs : the Investigational Drugs Journal|February 4, 2010
XL-184, a MET, VEGFR-2 and RET kinase inhibitor for the treatment of thyroid cancer, glioblastoma multiforme and NSCLCYing Zhang, Fadila Guessous, Alex Kofman, et al.Neuro-Oncology Practice|May 15, 2023
Hepatotoxicity from high-dose methotrexate in primary central nervous system lymphomaJoy C Zhang, Matthew J Stotts, Bethany Horton, et al.Neuro-Oncology|February 7, 2012
Management of treatment-associated toxicites of anti-angiogenic therapy in patients with brain tumorsTerri S Armstrong, Patrick Y Wen, Mark R Gilbert, et al.Cureus|February 22, 2021
Encephalomyeloradiculoneuropathy Revealing a Rare Case of Intravascular Large B-Cell LymphomaJehanne Aasfara, Fadila Guessous, Abderahmane Al Bouzidi, et al.Journal of Neuro-Oncology|February 8, 2012
Subependymal seeding of low-grade oligodendroglial neoplasms: a case seriesManal Nicolasjilwan, M Beatriz Lopes, James Larner, et al.Journal of Neuro-Oncology|April 1, 2009
Disseminated strongyloidiasis complicating glioblastoma therapy: a case reportDawit Aregawi, David Lopez, Mark Wick, et al.Pageof 29